---
title: "Zylox-Tonbridge Medical Technology Co., Ltd. (02190.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/02190.HK.md"
symbol: "02190.HK"
name: "Zylox-Tonbridge Medical Technology Co., Ltd."
industry: "Health Care Equipment"
---

# Zylox-Tonbridge Medical Technology Co., Ltd. (02190.HK)

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Location | HK Market |
| Website | [www.zyloxtb.com](https://www.zyloxtb.com) |

## Company Profile

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People’s Republic of China and internationally. The company offers a neurovascular product portfolio that covers a suite of products for various categ...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-17T04:30:09.000Z

**Overall: B (0.32)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 2 / 26 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 35.59% |  |
| Net Profit YoY | 495.91% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 2.28 |  |
| Dividend Ratio | 0.45% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 7.89B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 974.08M |  |


**Multi Score**: B

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 4.87% | C |
| Profit Margin | 16.98% | A |
| Gross Margin | 71.19% | A |

#### Growth Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 35.59% | A |
| Net Profit YoY | 495.91% | A |
| Total Assets YoY | 2.16% | C |
| Net Assets YoY | 3.34% | C |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 588.80% | C |
| OCF YoY | 35.59% | A |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.26 | D |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 9.78% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Zylox-Tonbridge Medical Technology Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "4.87%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "16.98%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "71.19%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "A",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "35.59%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "495.91%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "2.16%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "3.34%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "588.80%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "35.59%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.26",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "9.78%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | ANGELALIGN (HK.6699) | B | A | C | B | B | B |
| 02 | ZYLOXTB (HK.2190) | B | A | D | A | B | B |
| 03 | AK MEDICAL (HK.1789) | B | A | C | B | B | B |
| 04 | SCIENTECH (HK.2291) | A | B | D | A | B | B |
| 05 | MODERN DENTAL (HK.3600) | A | B | B | B | C | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 47.17 | 13/27 | 62.26 | 50.68 | 46.64 |
| PB | 2.28 | 15/27 | 2.36 | 2.19 | 1.80 |
| PS (TTM) | 8.01 | 17/27 | 8.49 | 7.84 | 7.15 |
| Dividend Yield | 0.45% | 11/27 | 0.49% | 0.46% | 0.43% |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-19T16:00:00.000Z

Total Analysts: **5**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 4 | 80% |
| Overweight | 1 | 20% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 23.40 |
| Highest Target | 31.98 |
| Lowest Target | 28.67 |

## References

- [Company Overview](https://longbridge.com/en/quote/02190.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/02190.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/02190.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.